THE IMPACT OF PHYSICOCHEMICAL CHARACTERISTICS ON THERAPEUTIC EFFICACY OF ANTICANCER NANOMATERIALS: A REVIEW
Abstract
Cancer is a global leading cause of death which suffers from treatment failures mainly due to intensive toxicity and lack of effectiveness of conventional drugs. The application of nanotechnology in cancer treatment promises to overcome the limitations of conventional drugs/drug delivery systems and improve their therapeutic efficacy. Materials at the nano scale possess novel properties that have an impact on their biological behaviour. The physiological interactions of nanomedicines in the body, which differ from those of conventional medicines, may provide benefits in pharmaceutical and/or clinical applications including, improvements in solubility, stability, efficacy, reduction of side effects, prevention and treatment of diseases. This paper discusses the unique characteristics and distinguished advantages of nanomaterials as anticancer drug carriers. Physicochemical properties of nanomaterials are critical parameters to their clinical translation. Hence, the impact of the main physicochemical properties on the efficacy of anitcancer nanomaterials, which are found to effective for cancer treatment and/or diagnosis, are presented. It is important to have reliable and robust characterization techniques that could enable relate physicochemical properties of nanomaterials with their in vivo behaviour. Brief explanation of the different techniques that can be used for studying the different physicochemical characteristics of nanomaterials is given. An important consideration, to achieve fast and successful development of nanotechnology-based anticancer drug products, is assessment and optimization of physicochemical and biopharmaceutical properties at the early stage. Obviously this requires collaboration among the different discovery and development scientists.
Keywords:
Nanothechnology, Cancer, Physicochemical properties, Characterization, Nanomaterials, Therapeutic efficacy.DOI
https://doi.org/10.25004/IJPSDR.2019.110203References
Emeje MO, Obidike IC, Akpabio EI, Ofoefule SI. Nanotechnology in Drug Delivery. In: Recent Advances in Novel Drug Carrier Systems, Sezer, A.D. (Ed.). Chapter 4, InTech Publisher, Rijeka, 2012, pp. 69-106.
Laouini A, Jaafer-Maalej C, Limayem-Blouza I, Sfar S, Charcosset C, Fessi H. Preparation, characterization and applications of liposomes: state of the art. Journal of colloid Science and Biotechnology. 2012; 1(2):147-168.
Gad SC. Pharmaceutical manufacturing handbook: production and processes. John Wiley & Sons, 2008.
Zhu M, Nie G, Meng H, Xia T, Nel A, Zhao Y. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. Acc. Chem. Res. 2012; 46(3):622-631.
Zhang J, Tang H, Liu Z, Chen B. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy. Int. J. Nanomed. 2017; 12:8483.
Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin pharmacol Ther. 2008; 83(5):761-769.
Markeb AA, El-Maali NA, Sayed DM, Osama A, Abdel-Malek MAY, Zaki AH, Elwanis MEA, Driscoll JJ. Synthesis, structural characterization, and preclinical efficacy of a novel paclitaxel-loaded alginate nanoparticle for breast cancer treatment. Int J Breast Cancer. 2016; 2016.
Amiji MM. Nanotechnology for cancer therapy. CRC press, 2006.
Guerrini L, Alvarez-Puebla R, Pazos-Perez N. Surface modifications of nanoparticles for stability in biological fluids. Materials. 2018; 11(7):1154.
Murugan C, Rayappan K, Thangam R, Bhanumathi R, Shanthi K, Vivek R, Thirumurugan R, Bhattacharyya A,
Sivasubramanian S, Gunasekaran P, Kannan S. Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy. Sci Rep. 2016; 6:34053.
Liu L, Ye Q, Lu M, Lo Y-C, Hsu Y-H, Wei M-C, Chen Y-H, Lo S-C, Wang S-J, Bain DJ, Ho C. A new approach to reduce toxicities and to improve bioavailabilities of platinum-containing anti-cancer nanodrugs. Sci Rep. 2015; 5:10881.
Zhang Y, Li R-J, Ying X, Tian W, Yao H-J, Men Y, Yu Y, Zhang L, Ju R-J, Wang X-X, Zhou J, Chen J-X, Li N, Lu W-L. Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer. Mol. Pharm. 2010; 8(1):162-175.
Liu Y,Yang M, Zhang J, Zhi X, Li C, Zhang C, Pan F, Wang K, Yang Y, Fuentea JM, Cui D. Human induced pluripotent stem cells for tumor targeted delivery of gold nanorods and enhanced photothermal therapy. ACS Nano. 2016; 10(2):2375-2385.
Kim CS, Mout R, Zhao Y, Yeh Y-C, Tang R, Jeong Y, Duncan B, Hardy JA, Rotello VM. Co-delivery of protein and small molecule therapeutics using nanoparticle-stabilized nanocapsules. Bioconjugate chem. 2015; 26(5):950-954.
Navya P, Daima HK. Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectives. Nano Converg. 2016; 3(1):1.
Santos-Carballal B, Aaldering L.J, Ritzefeld M, Pereira S, Sewald N, Moerschbacher BM, Götte M, Goycoolea FM. Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells. Sci Rep 2015; 5:13567.
Lin P-C, Lina S, Wanga PC, Sridhar R. Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv. 2014; 32(4):711-726.
Zhang X-Q, Xu X, Bertrand N, Pridgen E, Swamia A, Farokhzada OC. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Deliv Revi. 2012; 64(13):1363-1384.
Boverhof DR, David RM. Nanomaterial characterization: considerations and needs for hazard assessment and safety evaluation. Anal. Bioanal. Chem. 2010; 396(3):953-961.
Patri AK, Dobrovolskaia MA, Stern ST, McNeil SE. Nanotechnology for cancer therapy. CRC Press, 2006, pp. 120-152.
Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J. 2012; 14(2):282-295.
Kumar D, Meenan BJ, Mutreja I, D`sa R, Dixon D. Controlling the size and size distribution of gold nanoparticles: a design of experiment study. Int J Nanosci. 2012; 11(02):1250023.
Hoshyar N, Gray S, Han H, Bao G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine, 2016; 11(6):673-692.
Zhao P, Zheng M, Yue C, Luo Z, Gong P, Gao G, Sheng Z, Zheng C, Cai L. Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles. Biomaterials. 2014; 35(23):6037-6046.
Mozar FS, Chowdhury EH, Surface-modification of carbonate apatite nanoparticles enhances delivery and cytotoxicity of gemcitabine and anastrozole in breast cancer cells. Pharmaceutics. 2017; 9(2):21.
Khan IK, Saeed, Khan I. Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry, 2017.
Sykes EA, Dai Q, Sarsons CD, Chen J, Rocheleau JV, Hwang DM, Zheng G, Cramb DT, Rinker KD, Chan WC. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. PNAS. 2016; 113(9):201521265.
Christine V, Ponchel G, Polymer nanoparticles for nanomedicines. A guide for their design. Anticancer Res. 2017; 37:1544.
Toy R, Hyden E, Shoup C, Baskaran H, Karathanasis E. The effects of particle size, density and shape on margination of nanoparticles in microcirculation. Nanotechnology. 2011; 22(11):115101.
Chu M, Shao Y, Peng J, Dai X, Li H, Wu Q, Shi D. Near-infrared laser light mediated cancer therapy by photothermal effect of Fe3O4 magnetic nanoparticles. Biomaterials. 2013; 34(16):4078-4088.
Black KC, Wang Y, Luehmann HP, Cai X, Xing W, Pang B, Zhao Y, Cutler CS, Wang LV, Liu Y, Xia Y. Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution. ACS Nano. 2014; 8(5):4385-4394.
Alsaab H, Alzhrani R, Kesharwani P, Sau S, Boddu S, Lyer A. Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma. Pharmaceutics. 2017; 9(2):15.
Lee JH, Yeo Y. Controlled drug release from pharmaceutical nanocarriers. Chemical engineering science. 2015; 125:75-84.
Maji R, Dey NS, Satapathy BS, Mukherjee B, Mondal S. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. Int J Nanomedicine. 2014; 9:3107.
Alexis F, Pridgen EM, Langer R, Faronkhzad OC. Drug delivery. Springer, Berlin, 2010, pp. 55-86.
Arora S, Swaminathan SK, Kirtane A, Srivastava SK, Bhardwaj A, Singh S, Panyam J, Singh AP. Synthesis, characterization, and evaluation of poly (D, L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. Int J Nanomedicine. 2014; 9:2933.
Wang C, Xu H, Liang C, Liu Y, Li Z, Yang G, Cheng L, Li Y, Liu Z. Iron oxide@ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. ACS Nano, 2013; 7(8):6782-6795.
Mohamed AI, Hussain AK, Zayed GM, Shaykoon SM, Mahmoud RA. Preparation and Characterization of Cytotoxic DrugLoaded Gold Nanoparticles. Ijppr. 2016; 6(4):640-652.
Kirubakaran S, Thiruvenkatam V. Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering. IGI Global, 2015.
She W, Li N, Luo K, Guo C, wang G, Geng Y, Gu Z. Dendronized heparin− doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials. 2013; 34(9):2252-2264.
Nash MA, Lai JJ, Hoffman AS, Yager P, Stayton PS. “Smart” diblock copolymers as templates for magnetic-core gold-shell nanoparticle synthesis. Nano Lett. 2009; 10(1):85-91.
Misra P. Applied Spectroscopy and the Science of nanomaterials. Springer, 2014.
Slowing I, Trewyn BG, Lin VS-Y. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc. 2006; 128(46):14792-14793.
Mahalingam M, Krishnamoorthy K. Camptothecin loaded poly (methacyclic acid-Co-methyl-methyacrylate) nanoparticles: Fabrication, characterization and cytotoxicity studies. Int J Pharm Pharm Sci. 2015; 7(10):135-140.
Conde J, Tian F, de la Fuente JM, Baptista PV. Cancer Nanotheranostics: What Have We Learned So Far? Front Chem. 2016; 3:71.
Rodzinski A, Guduru R, Liang P, Hadjikhani A, Stewart T, Stimphil E, Runowicz C, Cote R, Altman N, Datar R, Khizroev S. Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles. Sci Rep. 2016; 6:20867.
Moore TL, Rodriguez-Lorenzo L, Hirsch V, Balog S, Urban D, Jud C, Rothen-Rutishauser B, Lattuada M, Petri-Fink A. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem Soc Rev. 2015; 44(17):6287-6305.
Gaonkar RH, Ganguly S, Dewanjee S, Sinha S, Gupta A, Ganguly S, Chattopadhyay D, Debnath MC. Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies. Sc Rep. 2017; 7(1):530.
Mahalingam M, Krishnamoorthy K. Fabrication, physicochemical characterization and evaluation of in vitro anticancer efficacy of a novel pH sensitive polymeric nanoparticles for efficient delivery of hydrophobic drug against colon cancer. J Appl Pharm Sci. 2015; 5(11):135-145.
Garg A, Visht S, Sharma PK, Kumar N. Formulation, characterization and application on nanoparticle: a review. Der Pharmacia Sin. 2011; 2(2):17-26.
Arabi S, Javar HA, Khoobi M. Preparation and Characterization of Modified Polyethyleneimine Magnetic Nanoparticles for Cancer Drug Delivery. J Nanomater. 2016; 2016.
Bhatia S. Natural polymer drug delivery systems. Springer, Cham, 2016, pp. 33-93.
Published
Abstract Display: 737 
PDF Downloads: 915 
